2-Bromo-4-(trifluoromethoxy)biphenyl, 95%, 500mg

1-(2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)ethyl)piperidine, 98%, 250mg

5-Bromo-2-methoxy-N-methylbenzenesulfonamide, 95.0%, 5g

2-(4-Dimethylamino-phenyl)-1 H -benzoimidazol-5-ylamine, 95+%, 250mg

2',6'-Difluoroacetophenone, 97.0%, 10g

(2E)-1-(4-fluorophenyl)-3-(furan-2-yl)prop-2-en-1-one, 95.0%, 10g

Ethyl 2-ethylhexanoate, 95.0%, 5g

6-Bromo-8-nitro-[1,2,4]triazolo[4,3-a]pyridine, 95.0%, 5g

N4-Hydroxycytidine>95.0%(HPLC)100mg

4'-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,1'-biphenyl]-2-ol, 95.0%, 5g

2,3-Dimethyl-1 H -indole-5-carboxylic acid ethyl ester, 95.0%, 250mg

2-phenyl-1,2,3,4-tetrahydroquinoline, 95%, 1g

Serological pipettes ROTILABO®, 10 ml, 4 x (50 x 1), 200 pieces